Laubach, Susan
Kim, Edwin H.
Greenhawt, Matthew
Bailey, Sally
Anagnostou, Aikaterini
Article History
Accepted: 5 February 2024
First Online: 5 March 2024
Compliance with Ethical Standards
:
: Susan Laubach reports personal fees from Aimmune Therapeutics, personal fees from Novartis, personal fees from Genentech, and personal fees from ARS Pharma, outside the submitted work. Edwin Kim reports personal fees from ALK, personal fees from Kenota Health, personal fees from Ukko Inc., personal fees from AllerGenis, personal fees from DBV Technologies, personal fees from Genentech, personal fees from Novartis, personal fees from Nutricia, personal fees from Revolo Biotherapeutics, grants from Food Allergy Research and Education (FARE), and grants from NIH-NIAID, outside the submitted work. Matthew Greenhawt reports personal fees from ALK-Abello, grants and personal fees from DBV, personal fees from Prota, grants and personal fees from Novartis, personal fees from Allergy Therapeutics, personal fees from Astra Zeneca, personal fees from Aquestive, personal fees from Bryn, personal fees from Nutricia, personal fees from Sanofi, during the conduct of the study; personal fees from Annals of Allergy Asthma and Immunology, personal fees from Multiple state/local medical societies, outside the submitted work; and Member of the Medical Advisory team for the Allergy and Asthma Foundation of America and the International Association for Food Protein Enterocolitis (nonfinancial). Member, Scientific Advisory Council, National Peanut Board (nonfinancial). Member, Core Outcome Measures for Food Allergy (COMFA) consortium, COST Action, Member, Brighton Criteria Collaboration Case Definition for Anaphylaxis working group 2.0, member, Joint Taskforce on Allergy Practice Parameters (all nonfinancial). Sally Bailey reports personal fees from ALK, personal fees from Optinose, personal fees from Sanofi, personal fees from Novartis, and personal fees from Regeneron, outside the submitted work. Aikaterini Anagnostou reports grants and personal fees from Novartis, grants and personal fees from Aimmune Therapeutics, personal fees from ALK, personal fees from EPG Health, grants and personal fees from FARE, and personal fees from DBV Technologies, outside the submitted work.
: This article does not contain any studies with human or animal subjects performed by any of the authors.